Neonatal S100B Protein Levels After Prenatal Exposure to Selective Serotonin Reuptake Inhibitors
The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: This study investigated neonatal S100B levels as a biomarker of prenatal selective serotonin reuptake inhibitor (SSRI) exposure. METHODS: Maternal (delivery; N = 53) and neonatal (cord; N = 52) serum S100B levels were compared between prenatally SSRI-exposed (maternal, N = 36; neonatal, N = 37; duration: 230 ± 71 days) and nonexposed (maternal, N = 17; neonatal, N = 15) groups. Measures of maternal depression and anxiety symptoms were assessed during the third trimester (33–36 weeks), and neonatal outcomes, including Apgar scores, birth weight, gestational age at birth, and symptoms of poor neonatal adaptation, were recorded. RESULTS: S100B levels were significantly lower in prenatally SSRI-exposed neonates than in nonexposed neonates, controlling for gestational age and third-trimester maternal mood (P = .036). In contrast, SSRI-exposed mothers had significantly higher maternal serum S100B levels, compared with nonexposed mothers (P = .014), even controlling for maternal mood in the third trimester. S100B levels were not associated with maternal or neonatal drug levels, duration of prenatal exposure, demographic variables, or risk for poor neonatal adaptation. CONCLUSIONS: Prenatal SSRI exposure was associated with decreased neonatal serum S100B levels, controlling for prenatal maternal mood. Neonatal S100B levels did not reflect neonatal behavioral outcomes and were not related to pharmacologic indices. These findings are consistent with prenatal alcohol and cocaine exposures, which also alter central serotonin levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“children and adolescents who are underweight, show excessive daytime sleepiness, and who have a history of atrial tachycardia, conduction disorders, hepatic or renal diseases are also at increased risk of adverse events when using SSRIs and SNRIs (e.g [83]).”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [83]
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Detection of Postnatal Depression: Development of the 10-item Edinburgh Postnatal Depression Scale
Cox, J. L., Holden, J. M., & Sagovsky, R. (1987) · British Journal of Psychiatry · doi:10.1192/bjp.150.6.782 · Cited by 14,183
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
The spectrum of behaviors influenced by serotonin
Lucki, I. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00139-5 · Cited by 1,158
Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn
Chambers, C. D., Hernandez-Diaz, S., Van Marter, L. J., Werler, M. M., Louik, C., Jones, K. L., & Mitchell, A. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052744 · Cited by 880
Oberlander, T. F., Warburton, W., Misri, S., Aghajanian, J., & Hertzman, C. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.898 · Cited by 551
Self-citationMoses-Kolko, E. L., Bogen, D., Perel, J., Bregar, A., Uhl, K., Levin, B., & Wisner, K. L. (2005) · JAMA · doi:10.1001/jama.293.19.2372 · Cited by 533
Serotonin and brain development: role in human developmental diseases
Whitaker-Azmitia, P. M. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00615-3 · Cited by 506
Use of Selective Serotonin-Reuptake Inhibitors in Pregnancy and the Risk of Birth Defects
Alwan, S., Reefhuis, J., Rasmussen, S. A., Olney, R. S., & Friedman, J. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066584 · Cited by 495
Huizink, A. C., Mulder, E. J. H., & Buitelaar, J. K. (2004) · Psychological Bulletin · doi:10.1037/0033-2909.130.1.115 · Cited by 473 · cited 1×
“(2) The Hamilton Rating Scale for Anxiety (HAM-A) is a 14item, clinician-administered scale that measures the severity of anxiety.”
MethodHuman brain dopamine receptors in children and aging adults
Seeman, P., Bzowej, N. H., Guan, H. ‐., Bergeron, C., Becker, L. E., Reynolds, G. P., Bird, E. D., Riederer, P., Jellinger, K., Watanabe, S., et al. (1987) · Synapse · doi:10.1002/syn.890010503 · Cited by 404
Serotonin as a developmental signal
Whitaker-Azmitia, P. M., Druse, M., Walker, P., & Lauder, J. M. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00071-x · Cited by 356
Laine, K., Heikkinen, T., Ekblad, U., & Kero, P. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.720 · Cited by 331
Neurotrophic protein S100 beta stimulates glial cell proliferation.
Selinfreund, R. H., Barger, S. W., Pledger, W. J., & Van Eldik, L. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3554 · Cited by 323
Whitaker-Azmitia, P. M., Murphy, R., & Azmitia, E. C. (1990) · Brain Research · doi:10.1016/0006-8993(90)90210-3 · Cited by 319
Maternal Selective Serotonin Reuptake Inhibitor Use During Pregnancy and Newborn Neurobehavior
Zeskind, P. S., & Stephens, L. E. (2004) · Pediatrics · doi:10.1542/peds.113.2.368 · Cited by 280
Winningham-Major, F., Staecker, J. L., Barger, S. W., Coats, S., & Van Eldik, L. J. (1989) · The Journal of cell biology · doi:10.1083/jcb.109.6.3063 · Cited by 274
S-100B but not NGF, EGF, insulin or calmodulin is a CNS serotonergic growth factor
Azmitia, E. C., Dolan, K., & Whitaker-Azmitia, P. M. (1990) · Brain Research · doi:10.1016/0006-8993(90)90942-5 · Cited by 230
Whitaker-Azmitia, P. M. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06668-2 · Cited by 226
Serum Biomarker Concentrations and Outcome after Pediatric Traumatic Brain Injury
Berger, R. P., Beers, S. R., Richichi, R., Wiesman, D., & Adelson, P. D. (2007) · Journal of Neurotrauma · doi:10.1089/neu.2007.0316 · Cited by 214
Oberlander, T. F., Reebye, P., Misri, S., Papsdorf, M., Kim, J., & Grunau, R. E. (2007) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.161.1.22 · Cited by 198
Self-citationMaternal Use of Selective Serotonin Reuptake Inhibitors and Risk of Congenital Malformations
Wogelius, P., Nørgaard, M., Gislum, M., Pedersen, L., Munk, E., Mortensen, P. B., Lipworth, L., & Sørensen, H. T. (2006) · Epidemiology · doi:10.1097/01.ede.0000239581.76793.ae · Cited by 185
Serotonin neurons, neuroplasticity, and homeostasis of neural tissue
Azmitia, E. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00022-6 · Cited by 184
Oberlander, T. F., Grunau, R. E., Fitzgerald, C., Papsdorf, M., Rurak, D., & Riggs, W. (2005) · Pediatrics · doi:10.1542/peds.2004-0420 · Cited by 164
Self-citationS‐100 proteins in the human peripheral nervous system
Gonzalez‐Martinez, T., Perez‐Piñera, P., Díaz‐Esnal, B., & Vega, J. A. (2003) · Microscopy Research and Technique · doi:10.1002/jemt.10304 · Cited by 154
Serum markers support disease-specific glial pathology in major depression
Schroeter, M. L., Abdul-Khaliq, H., Krebs, M., Diefenbacher, A., & Blasig, I. E. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.03.005 · Cited by 152
Neural Systems Underlying Arousal and Attention: Implications for Drug Abusea
ROBBINS, T. W., GRANON, S., MUIR, J. L., DURANTOU, F., HARRISON, A., & EVERITT, B. J. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09740.x · Cited by 149
S100B Protein in Biological Fluids: A Tool for Perinatal Medicine
Michetti, F., & Gazzolo, D. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.12.2097 · Cited by 147
Bhattacharyya, A., Oppenheim, R. W., Prevette, D., Moore, B. W., Brackenbury, R., & Ratner, N. (1992) · Journal of Neurobiology · doi:10.1002/neu.480230410 · Cited by 142
Whitaker‐Azmitia, P. M., & Azmitia, E. C. (1989) · Brain Research · doi:10.1016/0006-8993(89)90972-4 · Cited by 141
Oberlander, T. F., Warburton, W., Misri, S., Aghajanian, J., & Hertzman, C. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.037101 · Cited by 131
Self-citationS100B is increased in mood disorders and may be reduced by antidepressive treatment
Schroeter, M. L., Abdul-Khaliq, H., Diefenbacher, A., & Blasig, I. E. (2002) · NeuroReport · doi:10.1097/00001756-200209160-00021 · Cited by 124
Zhou, F. C., Sari, Y., Zhang, J. K., Goodlett, C. R., & Li, T. (2001) · Developmental Brain Research · doi:10.1016/s0165-3806(00)00144-9 · Cited by 123
Oberlander, T. F., Bonaguro, R. J., Misri, S. K., Papsdorf, M., Ross, C. J., & Simpson, E. M. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002007 · Cited by 116
Self-citationLinking emotion to the social brain: The role of the serotonin transporter in human social behaviour
Lesch, K. (2007) · EMBO Reports · doi:10.1038/sj.embor.7401008 · Cited by 111
Hetzel, G., Moeller, O., Evers, S., Erfurth, A., Ponath, G. D., Arolt, V., & Rothermundt, M. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1999-z · Cited by 93
Ramos, A. J., Rubio, M. D., Defagot, C., Hischberg, L., Villar, M. J., & Brusco, A. (2004) · Brain Research · doi:10.1016/j.brainres.2004.10.019 · Cited by 85
Akbari, H. M., Whitaker‐Azmitia, P. M., & Azmitia, E. C. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90259-3 · Cited by 84
Gazzolo, D., Vinesi, P., Marinoni, E., Iorio, R. D., Marras, M., Lituania, M., Bruschettini, P., & Michetti, F. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.7.998 · Cited by 84
Tramontina, A. C., Tramontina, F. F., Bobermin, L. D., Zanotto, C., Souza, D. F., Leite, M. C., Nardin, P., Gottfried, C., & Gonçalves, C. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.06.001 · Cited by 80
Infant Safety With Antipsychotic Therapy in Breast-Feeding: A Sytematic Review
Gentile, S. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0421 · Cited by 80
The S-100 protein causes an increase of intracellular calcium and death of PC12 cells
Fanò, G., Mariggiò, M. A., Angelella, P., Nicoletti, I., Antonica, A., Fulle, S., & Calissano, P. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90477-w · Cited by 79
Serotonin and Dopamine Synthesis in Phenylketonuria
Curtius, H. ‐., Niederwieser, A., Viscontini, M., Leimbacher, W., Wegmann, H., BLEHOVÁ, B., Rey, F., Schaub, J., & Schmidt, H. (1981) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-3860-4_16 · Cited by 77
Use of Contemporary Antidepressants during Breastfeeding
Gentile, S. (2007) · Drug Safety · doi:10.2165/00002018-200730020-00002 · Cited by 71
Prenatal Expression of 5-HT1C and 5-HT2 Receptors in the Rat Central Nervous System
Hellendall, R. P., Schambra, U. B., Liu, J. P., & Lauder, J. M. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1054 · Cited by 67
Hippocampal serotonin levels influence the expression of S100β detected by immunocytochemistry
Haring, J. H., Hagan, A., Olson, J., & Rodgers, B. (1993) · Brain Research · doi:10.1016/0006-8993(93)91195-x · Cited by 60
Clarke, C., Clarke, K., Muneyyirci, J., Azmitia, E., & Whitaker-Azmitia, P. M. (1996) · Developmental Brain Research · doi:10.1016/0165-3806(95)00192-1 · Cited by 51
Huether, G., Thömke, F., & Adler, L. (1992) · Developmental Brain Research · doi:10.1016/0165-3806(92)90059-6 · Cited by 49
Becker, L. E. (1991) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100031644 · Cited by 49
S100B protein levels in saliva: correlation with gestational age in normal term and preterm newborns
Gazzolo, D., Lituania, M., Bruschettini, M., Ciotti, S., Sacchi, R., Serra, G., Calevo, M. G., Corvino, V., Buonocore, G., & Michetti, F. (2005) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.12.006 · Cited by 49
Brewton, L. S., Haddad, L. B., & Azmitia, E. C. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02519-7 · Cited by 49
Roles for Serotonin in Neurodevelopment: More than just Neural Transmission
Pino, G., Moessner, R., Lesch, K., Lauder, J., & Persico, A. (2004) · Current Neuropharmacology · doi:10.2174/1570159043359495 · Cited by 44
Eriksen, J. L., Gillespie, R. A., & Druse, M. J. (2000) · Developmental Brain Research · doi:10.1016/s0165-3806(00)00029-8 · Cited by 38
S100 and Impact of ECT on Depression and Cognition
Arts, B., Peters, M., Ponds, R., Honig, A., Menheere, P., & van Os, J. (2006) · The Journal of ECT · doi:10.1097/01.yct.0000235925.37494.2c · Cited by 35
S100B content and SOD activity in amniotic fluid of pregnancies with Down syndrome
Netto, C. B. O., Siqueira, I. R., Fochesatto, C., Portela, L. V., Tavares, M. P., Souza, D. O., Giugliani, R., & Gonçalves, C. (2003) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2003.09.010 · Cited by 35
Whitaker‐Azmitia, P. M. (1998) · PubMed · Cited by 34
Prenatal stress reduces S100B in the neonatal rat hippocampus
van den Hove, D., Steinbusch, H. W. M., Bruschettini, M., Gazzolo, D., Frulio, R., Scheepens, A., Prickaerts, J., & Blanco, C. E. (2006) · Neuroreport · doi:10.1097/01.wnr.0000223391.74575.c9 · Cited by 34
Gazzolo, D., Kornacka, M., Bruschettini, M., Lituania, M., Giovannini, L., Serra, G., Majewska, U., & Michetti, F. (2003) · Clinical Chemistry · doi:10.1373/49.7.1215 · Cited by 30
WHITAKER‐AZMITIA, P. M. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09734.x · Cited by 26
Bruschettini, M., van den Hove, D., Gazzolo, D., Bruschettini, P., Blanco, C. E., & Steinbusch, H. W. M. (2005) · Developmental Brain Research · doi:10.1016/j.devbrainres.2005.07.003 · Cited by 24
Biochemical and clinical effects of tyrosine and tryptophan in the rett syndrome
Nielsen, J. B., Lou, H. C., & Andresen, J. (1990) · Brain and Development · doi:10.1016/s0387-7604(12)80197-5 · Cited by 20
Development of specificity and stereoselectivity of rat brain dopamine receptors
Miller, J. C., & Friedhoff, A. J. (1986) · International Journal of Developmental Neuroscience · doi:10.1016/0736-5748(86)90012-2 · Cited by 19
Yang, Y. H., Nam, M. S., & Yang, E. S. (2005) · Yonsei Medical Journal · doi:10.3349/ymj.2005.46.2.193 · Cited by 18
Specificity and sensitivity of S100B levels in amniotic fluid for Down syndrome diagnosis
Tort, A. B. L., Portela, L. V., Tavares, M. P., Gonçalves, C. A., Netto, C. B. O., Giugliani, R., & Souza, D. O. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.09.003 · Cited by 14
Serotonin Trophic Factors in Development, Plasticity and Aging
Whitaker‐Azmitia, P. M., & Azmitia, E. C. (1991) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7259-1_5 · Cited by 11
Cited by
Brummelte, S., Mc Glanaghy, E., Bonnin, A., & Oberlander, T. F. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2016.02.037 · Cited by 306
Self-citationThe S100B protein in biological fluids: more than a lifelong biomarker of brain distress
Michetti, F., Corvino, V., Geloso, M. C., Lattanzi, W., Bernardini, C., Serpero, L., & Gazzolo, D. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07612.x · Cited by 242
Oberlander, T. F., Gingrich, J. A., & Ansorge, M. S. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.201 · Cited by 236
Self-citationRayen, I., van den Hove, D. L., Prickaerts, J., Steinbusch, H. W., & Pawluski, J. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024003 · Cited by 176
Self-citationEndocrine substrates of cognitive and affective changes during pregnancy and postpartum.
Workman, J. L., Barha, C. K., & Galea, L. A. M. (2012) · Behavioral Neuroscience · doi:10.1037/a0025538 · Cited by 148
Self-citation
Metadata
- Authors
- Pawluski, J. L., Galea, L. A. M., Brain, U., Papsdorf, M., & Oberlander, T. F.
- Affiliations
- Departments of Pediatrics
- University of British Columbia (CA)
- BC Children's Hospital (CA)
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2009-10-01
- Volume
- 124
- Issue
- 4
- Pages
- e662-e670
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2130914256
- Cited by
- 65
- References
- 65
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 5 · 2018: 3 · 2017: 4 · 2016: 7 · 2015: 4 · 2014: 7 · 2013: 7 · 2012: 4
- FWCI
- 6.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PEDIATRICS (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- S100B, selective serotonin reuptake inhibitors, prenatal drug exposure, neonatal biomarkers, maternal depression, maternal anxiety, neonatal adaptation, cord serum, maternal serum, serotonin
- MeSH terms
- Analysis of Variance, Depressive Disorder, Female, Fetal Blood, Humans, Infant, Newborn, Longitudinal Studies, Male, Maternal-Fetal Exchange, Nerve Growth Factors, S100 Proteins, Pregnancy, Pregnancy Complications, Pregnancy Outcome, Pregnancy Trimester, Second, Prenatal Diagnosis, Prenatal Exposure Delayed Effects, Probability, Prospective Studies, Biomarkers, Confidence Intervals, Selective Serotonin Reuptake Inhibitors, Risk Assessment, Maternal Exposure, S100 Calcium Binding Protein beta Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.